Norethindrone acetate
- Product NDC
- 50742-267
- 11-digit product format
- 507420267
- Labeler code
- 50742
- Product ID
- 50742-267_ec08066e-8299-493e-b502-e56db778b15e
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- norethindrone acetate
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- Ingenus Pharmaceuticals, LLC
- Application
- ANDA206490
- Marketing category
- ANDA
- Marketing start
- 2019-08-29
- Substance
- NORETHINDRONE ACETATE
- Active strength
- 5 mg/1
- Pharmacologic classes
- Progesterone Congeners [CS], Progestin [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2026-12-31
- Current FDA listing
- Yes
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- Norethindrone acetate
- Listing expiration
- 2026-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| NORETHINDRONE ACETATE | 5 mg/1 |
Harmonized Identifiers#
Field, Values table| Field | Values |
|---|
| Unii | 9S44LIC7OJ |
| Rxcui | 1000405 |
DailyMed Product Concepts#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 50742-267-50 | Norethindrone acetate | 50 in 1 BOTTLE | TABLET | 50 | | 2 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 50742-267 | NORETHINDRONE ACETATE TABLET [INGENUS PHARMACEUTICALS, LLC] | 2 | Current NDC, Legacy NDC, 1 package rows | 20231207_2f39b608-cc62-4ff0-a52a-bc3343275269.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 50742-267-50 | 50742026750 | 50 TABLET in 1 BOTTLE (50742-267-50) | 50 tablet | 2019-08-29 | 0000-00-00 | No | No | Current |